Explore More View

A total of 16 research scientists and physicians received support from the Siteman Investment Program (SIP). SIP is a biannual research grant program at Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine. These individuals are leading unique cancer research projects that advance patient care through innovation.

The Foundation for Barnes-Jewish Hospital is pleased to announce it has raised $2 million to establish PREVENT, a multidisciplinary program at WashU Medicine and Barnes-Jewish Hospital focused on prevention and early detection of stomach and pancreatic cancers.

Inflammatory breast cancer (IBC) is a rare but highly aggressive cancer that progresses very quickly, often over the course of days or weeks.

Thanks to ongoing donor support through The Foundation for Barnes-Jewish Hospital, WashU Medicine researchers are making progress on better ways to tackle triple-negative breast cancer (TNBC).

Meet four research scientists and physicians who are raising awareness about the need for early cancer screenings, adjusting treatment plans for a greater and faster impact, and drastically improving diagnostic tools at Siteman Cancer Center to create more precise and personalized approaches to therapies.